Pfizer
PFE
PFE
2,388 hedge funds and large institutions have $173B invested in Pfizer in 2019 Q1 according to their latest regulatory filings, with 132 funds opening new positions, 905 increasing their positions, 1,112 reducing their positions, and 111 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
4% less capital invested
Capital invested by funds: $180B → $173B (-$6.79B)
19% less repeat investments, than reductions
Existing positions increased: 905 | Existing positions reduced: 1,112
39% less funds holding in top 10
Funds holding in top 10: 327 → 201 (-126)
Holders
2,388
Holding in Top 10
201
Calls
$1.53B
Puts
$1.29B
Top Buyers
| 1 | +$973M | |
| 2 | +$601M | |
| 3 | +$439M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$373M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$289M |
Top Sellers
| 1 | -$719M | |
| 2 | -$445M | |
| 3 | -$443M | |
| 4 |
LP
Longview Partners
St Peter Port,
Guernsey
|
-$372M |
| 5 |
CSIA
Charles Schwab Investment Advisory
San Francisco,
California
|
-$338M |